Oliver P. Keown (
Will Warburton is forum director, World Innovation Summit for Health, Qatar Foundation, and a senior policy fellow at the Centre for Health Policy, Institute of Global Health Innovation, Imperial College London.
Health Aff (Millwood). 2014 Sep;33(9):1620-6. doi: 10.1377/hlthaff.2014.0383.
Antimicrobial therapies have played an unquestionably important role in advancing modern medical and surgical care, treating animals, reducing the global burden of communicable disease, and prolonging human life expectancy. These transformational benefits are threatened because of the rapidly advancing phenomenon of antimicrobial resistance. As a result of complex factors across many sectors and international actors, the global impact of antimicrobial resistance is an escalating economic and health crisis. This article draws on the collective expertise and summit report of the Antimicrobial Resistance Working Group from the 2013 World Innovation Summit for Health, in Doha, Qatar. It defines a framework of principles and tasks for key policy makers to raise international awareness of antimicrobial resistance and lead transformative action through policy-driven improvements in sanitation, antimicrobial conservation, agricultural practices, and research and development.
抗菌治疗在推进现代医学和外科护理、治疗动物、减少传染病的全球负担和延长人类预期寿命方面发挥了不可置疑的重要作用。由于多种因素和国际行为体的共同作用,抗菌药物耐药性的全球影响是一场不断升级的经济和健康危机。本文借鉴了 2013 年在卡塔尔多哈举行的世界卫生创新峰会抗菌药物耐药性工作组的集体专业知识和峰会报告。它为主要决策者制定了一个原则和任务框架,以提高国际对抗菌药物耐药性的认识,并通过政策驱动的改善卫生、抗菌药物保存、农业实践以及研究和开发来引领变革性行动。